Description

Hydroxychloroquine Sulfate Tablets (Ai?Shen) are oral film-coated tablets formulated to deliver 0.2g of hydroxychloroquine sulfate per dose. Widely recognized for its antimalarial and immunomodulatory effects, this formulation is used in clinical settings for diseases like rheumatoid arthritis, lupus erythematosus, and malaria. Manufactured under strict pharmaceutical-grade standards by Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd., this product meets the quality and regulatory criteria expected for advanced research. Each box contains 24 tablets and is available for both wholesale and retail distribution. For laboratory research use only.

Product Specifications

Mechanism of Action & Research Applications

Hydroxychloroquine Sulfate acts by increasing the pH of intracellular compartments and inhibiting antigen presentation in immune cells, leading to suppression of inflammation. Its antimalarial activity stems from interference with parasite lysosomal function. In research, it is extensively studied for immunomodulatory effects in autoimmune disease models, as well as its antiviral properties in viral replication pathways. Hydroxychloroquine Sulfate Tablets (Ai?Shen) are widely used in preclinical and laboratory research focused on inflammation, infectious diseases, and immune system regulation. This product is intended solely for research purposes.

Side Effects (For Reference Only in Models)

Potential side effects observed in models include gastrointestinal discomfort, headache, visual disturbances, skin rash, and in long-term studies, retinal toxicity. Cardiotoxicity, including QT prolongation, may occur in dose-dependent settings. These effects should be considered in relevant experimental models.

Disclaimer

Hydroxychloroquine Sulfate Tablets (Ai?Shen) are strictly intended for laboratory research use only. Not for human consumption or therapeutic use.